On April 15, 2018, Wang Qi, head of Bossun Health, was invited to attend the 109th annual conference of the American Association for Cancer Research (AACR) in Chicago. The American Cancer Conference is the world’s largest and most influential cancer academic and product display event to date. The world’s top cancer research academic institutions, equipment R&D companies, and drug manufacturers will all gather here to exchange and discuss the latest cancer research topics. This year more than 600 companies has joined with this conference, and reached more than 22,000 exhibitors. The theme of this year’s conference is how to better apply medical innovation to the treatment of patients. The world’s top ten cancer drug manufacturers, Roche, Pfizer, Merck, and GlaxoSmithKline, have digitally displayed the latest cancer drugs. Many well-known cancer diagnosis and product research and development companies have also brought 3D technology, VR technology, and AI technology to this exhibition, demonstrating the application of these innovative technologies in cancer treatment and research.
Dr. Wang, the person in charge of Bossun Health, communicated with well-known companies and researchers who came to the conference to learn more about the latest products in cancer research from molecular diagnosis, genetic screening, directed therapy, to patient digital information management and collection. Bossun Health believes that through this annual conference, we will be able to bring more cutting-edge and advanced cancer treatment technologies, methods and research ideas to a wide range of domestic customers, cooperative institutions and researchers.
2018 AACR-Bossun Health attends the 2018 Annual conference of the American Association for Cancer Research (AACR) in Chicago